Submission Feedback

Following the submission of a package to FDA, EU, Japan or other notified body, it is not uncommon for feedback, whether informative or as a deficiency letter, to be provided following the submission review.  This forum serves to provide a place for the discussion of these findings to be had and advice on how to proceed to be shared.